Cancer, Lipids, and Metabolism
Cancer, Lipids, and Metabolism is a research topic within Cancer Research. Science Explorer counts 43k research works in it since 1950. 10.3% of them reached the world's top 10% most cited for their field and year.
This cluster of papers explores the role of lipid metabolism, including fatty acid synthesis, cholesterol metabolism, and statin use, in the pathogenesis and progression of cancer. It discusses the metabolic reprogramming of cancer cells, the impact of specific enzymes and receptors such as Fatty Acid Synthase and CD36, and the potential therapeutic implications of targeting lipid metabolism in cancer treatment.
- Lipid Metabolism
- Fatty Acid Synthase
- Cholesterol
- Statins
- Cancer
- Metabolic Reprogramming
- Lipogenesis
- CD36 Receptor
- HMG-CoA Reductase Inhibitors
- Acetyl-CoA Carboxylase
- Research works
- 43k fractional, since 1950
- In the world top 10%
- 4.5k per year above
- Top-10% rate
- 10.3% share of its works in the world top 10%
- Growth, 2018-21 → 2022-25
- +18% the tick is no change
- Largest producer
China
48% of the 10 largest, 2022-now
Which countries lead Cancer, Lipids, and Metabolism research?
By volume, China and the United States publish the most (3.3k and 1.7k works in 2022-now).
By volume, 2022-now
- 1
China 3.3k works
- 2
United States 1.7k works
- 3
India 355 works
- 4
Japan 303 works
- 5
Italy 280 works
- 6
South Korea 268 works
- 7
Germany 207 works
- 8
United Kingdom 201 works
- 9
France 152 works
- 10
Iran 147 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Cancer, Lipids, and Metabolism research?
By volume in 2022-now, Sun Yat-sen University publishes the most Cancer, Lipids, and Metabolism research, followed by Harvard University and Nanjing Medical University.
By volume, 2022-now
- 1
Sun Yat-sen University
China 109 works
- 2
Harvard University
United States 80 works
- 3
Nanjing Medical University
China 78 works
- 4
Shanghai Jiao Tong University
China 73 works
- 5
Zhejiang University
China 68 works
- 6
Fudan University
China 63 works
- 7
Sichuan University
China 62 works
- 8
Chinese Academy of Medical Sciences & Peking Union Medical College
China 62 works
- 9
Capital Medical University
China 59 works
- 10
Huazhong University of Science and Technology
China 57 works
Who are the leading researchers in Cancer, Lipids, and Metabolism?
The most-cited researchers publishing on Cancer, Lipids, and Metabolism include David Moher, Freddie Bray and Jacques Ferlay.
- 1
David Moher
Canada 898k citations
- 2
Freddie Bray
France 550k citations
- 3
Jacques Ferlay
France 486k citations
- 4
George Davey Smith
United Kingdom 435k citations
- 5
Ali H. Mokdad
United States 429k citations
- 6
Walter Churchill Willett
United States 411k citations
- 7
Mark J. Daly
United States 403k citations
- 8
Stacey L. Gabriel
United States 402k citations
- 9
Julian P. T. Higgins
United Kingdom 390k citations
- 10
Guido Kroemer
France 386k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Cancer, Lipids, and Metabolism research done?
The largest centres of Cancer, Lipids, and Metabolism research in 2022-now are Beijing (China), Shanghai (China), Guangzhou (China) and Nanjing (China). Among places with at least 20 works in it, it is an unusually large share of all research in Nantong and Hengyang.
Largest cities, 2022-now
Where it is the local speciality
- NantongCN · 30.7 works7.3×
- HengyangCN · 20.8 works6.6×
Location quotient: how much more of its research is in Cancer, Lipids, and Metabolism than the world average.
Where is the best place to study Cancer, Lipids, and Metabolism?
Among universities, judged by research, Sun Yat-sen University, Harvard University and Fudan University score highest, combining citation excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.
Universities only. The score blends citation excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.
Every institution in Cancer, Lipids, and Metabolism, country by countryIs Cancer, Lipids, and Metabolism research growing?
Output in 2022-2025 was 18% higher than in 2018-2021, peaking in 2022. The fastest-growing topics are Cancer, Lipids, and Metabolism.
The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.
Its share of all research
Growing output can still be a shrinking share: all of science grows. This is Cancer, Lipids, and Metabolism as a percentage of every work published that year, 0.039% in 2024.
Fractional works of Cancer, Lipids, and Metabolism over all fractional works that year. How the balance of science has shifted.
How much of it reaches the world top 10%
Year by year.
Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.
Discussion
Ask a question or share a note about Cancer, Lipids, and Metabolism. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.